Semafor1 min read
Alphabet’s biolab in funding talks at $40B valuation
The company hopes the new investment will accelerate its push to develop new drugs.
By Jeronimo GonzalezSemafor Tech
Read the full story
Originally published by Semafor Tech on Oct 8, 2026.
Comments
Sign in to join the discussion.